Samsung was world’s second-biggest pill maker in Q1 2024

Samsung was the world’s second-biggest pill model throughout Q1 2024. This can be a good outcome, however the South Korean agency might have completed higher, as its gross sales have dropped barely in comparison with the primary quarter of final yr. Whereas Apple’s gross sales additionally tanked, Chinese language pill makers managed to extend their gross sales.

Over 6.7 million Galaxy Tabs had been shipped in Q1 2024

Based on the most recent figures from Worldwide Information Company (IDC), Samsung ranked second globally by way of pill gross sales. It shipped 6.7 million tablets throughout Q1 2024 and captured a 21.7% share of the market. That is 5.8% fewer shipments in comparison with Q1 2023. The corporate launched 4 reasonably priced tablets—Galaxy Tab A9, Galaxy Tab A9+, Galaxy Tab S9 FE, and Galaxy Tab S9 FE+—in This autumn 2023 and the Galaxy Tab S6 Lite (2024) in Q1 2024. So, most of its current launches had been reasonably priced fashions, and it’s anticipated to launch the Galaxy Tab S10 early subsequent yr.

Apple ranked first with shipments of 9.9 million iPads and a market share of 32%. In comparison with Q1 2023, iPad gross sales tanked by 8.5%. It has been practically a yr and a half since Apple launched any iPad. Nevertheless, it’s anticipated to launch two new iPad Execs with OLED screens from Samsung and M4 chips and two new iPad Airs with the M2 chip tomorrow.

Huawei improved its pill gross sales by a powerful 43.6% (probably principally in China) to succeed in cargo figures of two.9 million and a market share of 9.4%. Lenovo shipped 2.1 million tablets, reaching a market share of seven%. Its year-over-year development stood at 13.2%, which is first rate. Xiaomi confirmed a staggering enchancment of 92.6% to succeed in pill shipments of 1.8 million and a market share of 5.9%.

Total, the pill market improved by an insignificant margin (0.5%) in comparison with Q1 2024. Over 30.8 million tablets had been shipped globally in Q1 2024. Different manufacturers accounted for twenty-four% of all pill gross sales in the course of the first quarter of this yr.